SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
P. Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, M. Navares-Gómez, G. Mejía-Abril, M. Román, S. Martín-Vílchez, D. Ochoa, F. Abad‐Santos
Journal of Personalized Medicine